A 35 year-old Breton SME
Laboratoire Benewmedical, based in Melesse, distributes innovative medical devices having high medical and economic value. The company sources and negotiates distribution contracts; consequently it is the guarantor for the market release of the product for which it has a mandate to distribute, and is also the guarantor of its quality and safety. With a range of approximately 800 product references, the company operates in three distinct product divisions: regenerative surgery, general surgery and the community healthcare sector. The devices are primarily intended for public and private-sector hospitals and are most commonly used in operating theatres.
Alongside Jérémy Glardon and Damien Bordier, Axio Capital has acquired a stake in the Breton group. This capital-intensive reorganization follows on from the wish expressed by Noël Laurent, founder and main shareholder of Benewmedical, to organize the transfer of the company he founded in 1989. Following this deal, Axio Capital has a 67.5% stake in the company.
A French and international ambition on a high-potential market
Specialized at the outset solely in trading, the company started its shift to manufacturing with a bold and avant-garde positioning in innovative surgical technologies, more particularly in the field of regenerative surgery.
Enjoying veritable growth potential on both the French and international markets, the company’s ambition is to become a leading player in the field of regenerative surgery. This ambition goes hand in hand with the reinforcement of the general surgery and community healthcare division for the distribution part.
Benewmedical
Transcription textuelle sur Youtube
- Cliquez sur les 3 points horizontaux situés sous la vidéo.
- Puis Afficher la transcription.
Lire le contenu embarqué sur le site de la plateforme. Nouvelle fenêtre